Australian scientists have discovered how the immune system can control melanoma, a mechanism which could be used to enhance cancer treatments.
Published today in Nature, Peter Doherty Institute for Infection and Immunity (Doherty Institute) and Telethon Kids Institute researchers investigated the role of a particular immune cell, tissue-resident memory T (TRM) cells, in controlling melanoma.
TRM cells were able to control the tumour in the mice for the life of the animal, which is likely to equate to decades of protection in humans.
University of Melbourne PhD student, Simone Park from the Doherty Institute, created an imaging model to study TRM cells’ and melanoma in a mouse model.
“Using a special microscope, we could see individual melanoma cells sitting in the skin of the mouse, and could watch the T cells move through the skin, find the melanoma cells and control the growth of those cells,” Ms Park explained.
One of the main issues for cancer patients is that there is always a risk that the tumour can come back years later, after surgery or chemotherapy.
Previous research has shown that small numbers of cancer cells persist in the body after treatment and that the immune system probably keeps the cancer cells under control but this study in mice could study the immune system directly. This is work that could never be done in people.
“I was able to see through moving images that these TRM cells are important for maintaining the control of the tumour cells; if you remove the TRM cells you have a break in that control and the cancer can start to grow back again,” Ms Park said.
“If you could make more of these TRM cells through immunotherapies, or enhance the activity of those that are already there in some way, you could boost anti-tumour immunity.”
Senior author on the paper, University of Melbourne Associate Professor Thomas Gebhardt, Laboratory Head at the Doherty Institute, said an increase of TRM cells has already been associated with better outcomes in cancer patients, but the way they work to suppress tumours has remained unknown.
“The principal of cutting-edge immunotherapies currently in clinical practise is that they generate a T-cell response. But if we can hone in on one type of T-cell – the TRM cells specifically, we could have an even bigger impact on stopping cancers from coming back,” Associate Professor Gebhardt said.
“We now have a much better understanding of which T-cells are important in controlling skin cancers and how those cells are working but there is still much more work to do to make these cells work even better,” Associate Professor Gebhardt said.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Health Beat: Advanced melanoma trial when Keytruda alone is not enough on January 2, 2019 at 11:42 pm
LOS ANGELES - Patients with metastatic melanoma have faced grim prospects. The American cancer society says the five-year survival rate is only 15 percent. That started changing when the FDA approved ... […]
- New and improved treatments for melanoma on January 2, 2019 at 9:52 am
Metastic Melanoma is the most serious and life threatening type of skin cancer. However, a new treatment has been approved by the FDA. Learn more about this new development from Dr. Anna Pavlick ... […]
- Global Non-Melanoma Skin Cancer Market 2018-2022 | Increase in Incidence of Non-Melanoma Skin Cancer Symptoms to Boost Demand | Technavio on January 2, 2019 at 5:40 am
LONDON--(Business Wire)--Technavio analysts forecast the global non-melanoma skin cancer market to grow at a CAGR of close to 6% during the forecast period, according to their latest market research r... […]
- SLE linked to increased risk for 16 cancers, decreased risk for melanoma on January 2, 2019 at 2:37 am
Systemic lupus erythematosus is associated with an increased risk for 16 cancers, including Hodgkin’s and non-Hodgkin’s lymphoma, leukemia and multiple myeloma, but a decreased risk for prostate cance... […]
- The end of skin cancer? Breakthrough as Australian scientists discover a cell that can 'put melanoma tumours to sleep' on December 31, 2018 at 3:46 pm
Scientists have made a breakthrough discovery that could open up revolutionary treatments for skin cancer. Research has uncovered that special immune cells have the power to put melanoma tumours 'to s... […]
- Hopes of melanoma breakthrough from cells that 'put cancer to sleep' on December 31, 2018 at 9:00 am
They fight viruses and bacteria in our skin, brain, lungs and gut. Now Australian scientists have also discovered that these special immune cells have the power to put melanoma tumours ‘‘to sleep’’, p... […]
- Global Melanoma Cancer Diagnostics Market Expectations & Growth Trends Highlighted until 2028 on December 28, 2018 at 4:33 am
The report on the melanoma cancer diagnostics market provides key insights, forecast, and in-depth analysis on the market. The melanoma cancer diagnostics market report also includes macro-economic an... […]
- University of Queensland to Revolutionize Early Detection of Melanoma through Installation of 15 Canfield VECTRA WB360 Imaging Systems on December 27, 2018 at 5:32 am
PARSIPPANY, N.J., Dec. 27, 2018 /PRNewswire/ -- The University of Queensland's Diamantina Institute received a $10 million grant for melanoma research. Part of this money will be used to install ... […]
- Mom’s melanoma leads to Israeli device for early detection on December 24, 2018 at 1:38 am
Ofir Aharon was in the last year of his PhD studies in electro-optics when his mother was diagnosed with melanoma. Learning all he could about this deadly form of skin cancer, Aharon came to the concl... […]
- Researchers make sense out of the chaos of melanoma on December 21, 2018 at 6:56 am
New drivers of metastasis in melanoma that define poor prognosis in patients: In red, imaging by fluorescence microscopy of p62 in melanoma cells. Red foci correspond to large complexes of p62 ... […]
via Bing News